Coordinate loss of fragile gene expression in pancreatobiliary cancers: Correlations among markers and clinical features

Annals of Surgical Oncology

Volumn 16, Issue 8, 2009, Pages 2331-2338

  Bloomston, Mark ^a   Kneile, Jeffrey ^a   Butterfield, Matthew ^a   Dillhoff, Mary ^a   Muscarella, Peter ^a   Ellison, E Christopher ^a   Melvin, W Scott ^a   Croce, Carlo M ^a   Pichiorri, Flavia ^a   Huebner, Kay ^a   Frankel, Wendy L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; TUMOR MARKER;

ADULT; AGED; AMPULLARY CANCER; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PANCREAS CANCER; TUMOR SUPPRESSOR GENE; WWOX GENE;

ACID ANHYDRIDE HYDROLASES; AGED; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS; OXIDOREDUCTASES; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 67650996249     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0507-4     Document Type: Article

References (35)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66
2. D Iliopoulos G Guler SY Han T Druck M Ottey KA McCorkell 2006 Roles of FHIT and WWOX fragile genes in cancer Cancer Lett 232 27 36
3. T Kuroki Y Tajima J Furui T Kanematsu 2006 Common fragile genes and digestive tract cancers Surg Today 36 1 5
4. R Shridhar V Shridhar X Wang W Paradee M Dugan F Sarkar 1996 Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors Cancer Res 56 4347 4350
5. W Hilgers BG Koerkamp J Geradts DJ Tang CJ Yeo RH Hruban 2000 Genomic FHIT analysis in RER + and RER- adenocarcinomas of the pancreas Genes Chromosomes Cancer 27 239 243
6. C Sorio A Baron S Orlandini G Zamboni P Pederzoli K Huebner 1999 The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers Cancer Res 59 1308 1314
7. T Kuroki S Yendamuri F Trapasso A Matsuyama RI Aqeilan H Alder 2004 The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis Clin Cancer Res 10 2459 2465
8. S Nakayama S Semba N Maeda RI Aqeilan K Huebner H Yokozaki 2008 Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells Cancer Sci 99 1370 1376
9. PS Moore S Beghelli G Zamboni A Scarpa 2003 Genetic abnormalities in pancreatic cancer Mol Cancer 2 7
10. A Maitra RH Hruban 2008 Pancreatic cancer Annu Rev Pathol 3 157 188
11. G Guler A Uner N Guler SY Han D Iliopoulos WW Hauck 2004 The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma Cancer 100 1605 1614
12. G Guler A Uner N Guler SY Han D Iliopoulos P McCue 2005 Concordant loss of fragile gene expression early in breast cancer development Pathol Int 55 471 478
13. F Trapasso F Pichiorri M Gaspari T Palumbo RI Ageilan E Gaudio 2008 Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells J Biol Chem 283 13736 13744
14. PM Hwang F Bunz J Yu C Rago TA Chan MP Murphy 2001 Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells Nat Med 7 1111 1117
15. G Liu X Chen 2002 The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis Oncogene 21 7195 7204
16. M Bloomston WL Frankel F Petrocca S Volinia H Alder JP Hagan 2007 MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis JAMA 297 1901 1908
17. M Bloomston A Bhardwaj EC Ellison WL Frankel 2006 Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique Dig Surg 23 74 79
18. M Bloomston EC Ellison P Muscarella O Al-Saif EW Martin WS Melvin 2007 Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer Ann Surg Oncol 14 211 217
19. RI Aqeilan T Kuroki Y Pekarsky O Albagha F Trapasso R Baffa 2004 Loss of WWOX expression in gastric carcinoma Clin Cancer Res 10 3053 3058
20. J Cao XP Chen WL Li J Xia H Du WB Tang 2007 Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition World J Gastroenterol 13 1018 1026
21. X Feng L Li Y Gao J Zhang J Ying T Xiao 2007 Fhit protein expression in lung cancer studied by high-throughput tissue microarray Bull Cancer 94 E8 E11
22. G Terry L Ho P Londesborough C Duggan A Hanby J Cuzick 2007 The expression of FHIT PCNA and EGFR in benign and malignant breast lesions Br J Cancer 96 110 117
23. G Sozzi U Pastorino L Moiraghi E Tagliabue F Pezzella C Ghirelli 1998 Loss of FHIT function in lung cancer and preinvasive bronchial lesions Cancer Res 58 5032 5037
24. B Simon D Bartsch P Barth N Prasnikar K Münch A Blum 1998 Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines Cancer Res 58 1583 1587
25. T Tsujiuchi Y Sasaki T Kubozoe Y Konishi M Tsutsumi 2003 Alterations in the Fhit gene in pancreatic duct adenocarcinomas induced by N-nitrosobis(2- oxopropyl)amine in hamsters Mol Carcinog 36 60 66
26. KR Dumon H Ishii A Vecchione F Trapasso G Baldassarre F Chakrani 2001 Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer Cancer Res 61 4827 4836
27. M Koda K Yashima K Kawaguchi H Andachi A Hosoda G Shiota 2003 Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma Cancer Lett 199 131 138
28. E Riquelme M Tang S Baez A Diaz M Pruyas II Wistuba 2007 Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma Cancer Lett 250 100 106
29. L Chen SF Tao YX Zheng 2006 Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater Hepatogastroenterology 53 45 50
30. D Fong M Steurer P Obrist 2006 Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance J Clin Pathol 61 31 35
31. C Iacono G Verlato G Zamboni A Scarpa E Montresor P Capelli 2007 Adenocarcinoma of the ampulla of Vater: T-Stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors J Gastrointest Surg 11 578 588
32. R Lucito S Suresh K Walter A Pandey B Lakshmi A Krasnitz 2007 Copy-number variants in patients with a strong family history of pancreatic cancer Cancer Biol Ther 6 1592 1599
33. G Guler D Iliopoulos N Guler C Himmetoglu M Hayran K Huebner 2007 Wwox and Ap2gamma expression levels predict tamoxifen response Clin Cancer Res 13 6115 6121
34. RI Aqeilan CM Croce 2007 WWOX in biological control and tumorigenesis J Cell Physiol 212 307 310
35. NS Chang LJ Hsu YS Lin FJ Lai HM Sheu 2007 WW domain-containing oxidoreductase: a candidate tumor suppressor Trends Mol Med 13 12 22